Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard B Rothman

Showing results (31-40 of 159) with videos related to

Pageof 16
Sort By:
Pharmacological Reviews|March 30, 2011
Neuropharmacology of the naturally occurring kappa-opioid hallucinogen salvinorin AChristopher W Cunningham, Richard B Rothman, Thomas E Prisinzano
Progress in Brain Research|September 6, 2008
Dopamine/serotonin releasers as medications for stimulant addictionsRichard B Rothman, Bruce E Blough, Michael H Baumann
Neuroscience Letters|March 16, 2004
A study of bile acids as opioid receptor ligands in rat brain membranesNora V Bergasa, Christine M Dersch, Richard B Rothman
Annals of the New York Academy of Sciences|November 2, 2017
In Vivo Correlates of Central Serotonin Function after High-Dose Fenfluramine AdministrationMichael H Baumann, Mario A Ayestas, Richard B Rothman
Annals of the New York Academy of Sciences|July 10, 2002
Appetite suppressants as agonist substitution therapies for stimulant dependenceRichard B Rothman, Bruce E Blough, Michael H Baumann
Trends in Pharmacological Sciences|October 24, 2006
Dual dopamine-5-HT releasers: potential treatment agents for cocaine addictionRichard B Rothman, Bruce E Blough, Michael H Baumann
Annals of the New York Academy of Sciences|November 2, 2017
Neurochemical and Neuroendocrine Effects of Ibogaine in Rats: Comparison to MK-801Michael H Baumann, Richard B Rothman, Syed F Ali
Drug and Alcohol Dependence|November 13, 2010
Serotonin (5-HT) precursor loading with 5-hydroxy-l-tryptophan (5-HTP) reduces locomotor activation produced by (+)-amphetamine in the ratMichael H Baumann, Zakia Williams, Dorota Zolkowska, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 10, 2013
Nonclassical pharmacology of the dopamine transporter: atypical inhibitors, allosteric modulators, and partial substratesKyle C Schmitt, Richard B Rothman, Maarten E A Reith
Synapse (New York, N.Y.)|July 22, 2004
3,4-methylenedioxymethamphetamine (MDMA) administration to rats decreases brain tissue serotonin but not serotonin transporter protein and glial fibrillary acidic proteinXiaoying Wang, Michael H Baumann, Heng Xu, et al.
Pageof 16

Showing results (31-40 of 159) with videos related to

Sort By:
Pageof 16
Pharmacological Reviews|March 30, 2011
Neuropharmacology of the naturally occurring kappa-opioid hallucinogen salvinorin AChristopher W Cunningham, Richard B Rothman, Thomas E Prisinzano
Progress in Brain Research|September 6, 2008
Dopamine/serotonin releasers as medications for stimulant addictionsRichard B Rothman, Bruce E Blough, Michael H Baumann
Neuroscience Letters|March 16, 2004
A study of bile acids as opioid receptor ligands in rat brain membranesNora V Bergasa, Christine M Dersch, Richard B Rothman
Annals of the New York Academy of Sciences|November 2, 2017
In Vivo Correlates of Central Serotonin Function after High-Dose Fenfluramine AdministrationMichael H Baumann, Mario A Ayestas, Richard B Rothman
Annals of the New York Academy of Sciences|July 10, 2002
Appetite suppressants as agonist substitution therapies for stimulant dependenceRichard B Rothman, Bruce E Blough, Michael H Baumann
Trends in Pharmacological Sciences|October 24, 2006
Dual dopamine-5-HT releasers: potential treatment agents for cocaine addictionRichard B Rothman, Bruce E Blough, Michael H Baumann
Annals of the New York Academy of Sciences|November 2, 2017
Neurochemical and Neuroendocrine Effects of Ibogaine in Rats: Comparison to MK-801Michael H Baumann, Richard B Rothman, Syed F Ali
Drug and Alcohol Dependence|November 13, 2010
Serotonin (5-HT) precursor loading with 5-hydroxy-l-tryptophan (5-HTP) reduces locomotor activation produced by (+)-amphetamine in the ratMichael H Baumann, Zakia Williams, Dorota Zolkowska, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 10, 2013
Nonclassical pharmacology of the dopamine transporter: atypical inhibitors, allosteric modulators, and partial substratesKyle C Schmitt, Richard B Rothman, Maarten E A Reith
Synapse (New York, N.Y.)|July 22, 2004
3,4-methylenedioxymethamphetamine (MDMA) administration to rats decreases brain tissue serotonin but not serotonin transporter protein and glial fibrillary acidic proteinXiaoying Wang, Michael H Baumann, Heng Xu, et al.
Pageof 16